Increasing electro-gene transfer of nucleic acid molecules into host tissue
CA 2468246 A1 · Owner: Mennuni, Carmela · Inventors: Mennuni, Carmela; Fattori, Elena; La Monica, Nicola
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of delivering a pharmaceutical agent such as a nucleic acid , molecule, to a vertebrate host is disclosed which comprises combining the synergistic steps of electrical stimulation with administration of a biologically active amount of hyaluronidase. Additionally formulations which , comprise hyaluronidase and a pharmaceutical agent such as a nucleic acid , molecule, are disclosed. The hyaluronidase preparation is preferably administered prior to or simultaneous with the pharmaceutical agent and in conjunction with an applied electrical stimulation thus affecting increased , transfer of the population of a pharmaceutical agent into the target tissue when compared to the affect …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.